Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Arcutis Biotherapeutics Stock News

ARQTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Q1 2025 Earnings in 5 days from now on Tue May 6th, after the market close

Conference call scheduled in 5 days at 16:30 PM Click to view the webcast

Arcutis Biotherapeutics (ARQT) Forecast

News

Earnings Arcutis Biotherapeutics (ARQT) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest Arcutis Biotherapeutics Stock News | NASDAQ:ARQT | Benzinga

Get the latest news on Arcutis Biotherapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Arcutis Biotherapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, April 10, 2025

Arcutis CFO David Topper To Retire, Latha Vai...
Benzinga Newsdesk - Apr 10, 2025, 4:31PM

Wednesday, April 09, 2025

Needham Reiterates Buy on Arcutis Biotherapeu...
Benzinga Newsdesk - Apr 9, 2025, 8:00AM

Thursday, April 03, 2025

Guggenheim Reiterates Buy on Arcutis Biothera...
Benzinga Newsdesk - Apr 3, 2025, 10:27AM
Demystifying Arcutis Biotherapeutics: Insights From 9 Analyst Reviews
Benzinga Insights - Apr 3, 2025, 8:00AM
HC Wainwright & Co. Reiterates Buy on Arcutis...
Benzinga Newsdesk - Apr 3, 2025, 6:40AM
Needham Reiterates Buy on Arcutis Biotherapeu...
Benzinga Newsdesk - Apr 3, 2025, 6:20AM

Wednesday, April 02, 2025

Arcutis And Padagis Announces Agreement To St...
Benzinga Newsdesk - Apr 2, 2025, 1:18PM

Tuesday, March 25, 2025

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs
Avi Kapoor - Mar 25, 2025, 8:16AM

Sunday, March 23, 2025

Celsius, Lucid And Signet Are Among Top 10 Mid-Cap Gainers Last Week (Mar 17-Mar 21): Are The Others In Your Portfolio?
Lekha Gupta - Mar 23, 2025, 5:28PM

Monday, March 17, 2025

What's Going On With Arcutis Biotherapeutics Stock Monday?
Dylan Berman - Mar 17, 2025, 4:10PM
Arcutis Biotherapeutics shares are trading hi...
Benzinga Newsdesk - Mar 17, 2025, 1:42PM
The Health Canada Has Approved Arcutis' Appro...
Benzinga Newsdesk - Mar 17, 2025, 7:06AM

Tuesday, March 11, 2025

Jefferies Maintains Buy on Arcutis Biotherape...
Benzinga Newsdesk - Mar 11, 2025, 2:57PM

Friday, February 28, 2025

Arcutis To Present At 83rd American Academy O...
Benzinga Newsdesk - Feb 28, 2025, 9:02AM

Thursday, February 27, 2025

Goldman Sachs Maintains Neutral on Arcutis Bi...
Benzinga Newsdesk - Feb 27, 2025, 11:40AM

Wednesday, February 26, 2025

HC Wainwright & Co. Reiterates Buy on Arcutis...
Benzinga Newsdesk - Feb 26, 2025, 12:22PM
Mizuho Maintains Outperform on Arcutis Biothe...
Benzinga Newsdesk - Feb 26, 2025, 11:08AM
Arcutis Biotherapeutics shares are trading hi...
Benzinga Newsdesk - Feb 26, 2025, 8:39AM
U.S. FDA Accepts Supplemental New Drug Applic...
Benzinga Newsdesk - Feb 26, 2025, 8:07AM
A Glimpse Into The Expert Outlook On Arcutis Biotherapeutics Through 5 Analysts
Benzinga Insights - Feb 26, 2025, 7:00AM
Needham Reiterates Buy on Arcutis Biotherapeu...
Benzinga Newsdesk - Feb 26, 2025, 6:19AM

Tuesday, February 25, 2025

Arcutis Biotherapeutics shares are trading hi...
Benzinga Newsdesk - Feb 25, 2025, 4:29PM
Arcutis Biotherapeutics Q4 2024 GAAP EPS $(0....
Benzinga Newsdesk - Feb 25, 2025, 4:02PM
Earnings Scheduled For February 25, 2025
Benzinga Insights - Feb 25, 2025, 3:32AM

Monday, February 24, 2025

Guggenheim Reiterates Buy on Arcutis Biothera...
Benzinga Newsdesk - Feb 24, 2025, 10:17AM
Arcutis Announces Results For ZORYVE Cream In...
Benzinga Newsdesk - Feb 24, 2025, 8:06AM

Wednesday, February 12, 2025

Watching Arcutis Biotherapeutics; Traders Cir...
Benzinga Newsdesk - Feb 12, 2025, 3:30PM

Monday, February 10, 2025

4 Analysts Have This To Say About Arcutis Biotherapeutics
Benzinga Insights - Feb 10, 2025, 2:00PM
Guggenheim Reiterates Buy on Arcutis Biothera...
Benzinga Newsdesk - Feb 10, 2025, 9:27AM

Monday, January 13, 2025

Demystifying Arcutis Biotherapeutics: Insights From 5 Analyst Reviews
Benzinga Insights - Jan 13, 2025, 8:01AM
HC Wainwright & Co. Reiterates Buy on Arcutis...
Benzinga Newsdesk - Jan 13, 2025, 6:45AM
Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Jan 13, 2025, 5:45AM
Needham Maintains Buy on Arcutis Biotherapeut...
Benzinga Newsdesk - Jan 13, 2025, 5:30AM

Sunday, January 12, 2025

Arcutis Biotherapeutics Reported Sunday, Prel...
Benzinga Newsdesk - Jan 12, 2025, 4:26PM

Tuesday, January 07, 2025

Arcutis Biotherapeutics shares are trading hi...
Benzinga Newsdesk - Jan 7, 2025, 12:57PM
Mizuho Maintains Outperform on Arcutis Biothe...
Benzinga Newsdesk - Jan 7, 2025, 11:09AM

Monday, December 30, 2024

This American Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday
Avi Kapoor - Dec 30, 2024, 9:47AM
This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Avi Kapoor - Dec 30, 2024, 7:54AM
HC Wainwright & Co. Initiates Coverage On Arc...
Benzinga Newsdesk - Dec 30, 2024, 6:54AM

Monday, December 16, 2024

Arcutis Submits ZORYVE Cream 0.05% Supplement...
Benzinga Newsdesk - Dec 16, 2024, 8:07AM

Thursday, November 07, 2024

Needham Reiterates Buy on Arcutis Biotherapeu...
Benzinga Newsdesk - Nov 7, 2024, 6:21AM

Wednesday, November 06, 2024

Arcutis Biotherapeutics Q3 2024 GAAP EPS $(0....
Benzinga Newsdesk - Nov 6, 2024, 4:00PM

Thursday, October 24, 2024

Arcutis Presents New Patient-Reported Outcome...
Benzinga Newsdesk - Oct 24, 2024, 8:01AM

Tuesday, October 22, 2024

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q4
Avi Kapoor - Oct 22, 2024, 7:36AM

Monday, October 21, 2024

Health Canada Approves Arcutis' Zoryve (Roflu...
Benzinga Newsdesk - Oct 21, 2024, 7:04AM

Friday, October 18, 2024

Arcutis Gains Health Canada Approval For ZORY...
Benzinga Newsdesk - Oct 18, 2024, 8:22AM

Wednesday, September 25, 2024

Arcutis Reports ZORYVE Cream Shows AD Relief ...
Benzinga Newsdesk - Sep 25, 2024, 2:35AM

Tuesday, September 24, 2024

FDA Accepts Arcutis' Supplemental New Drug Ap...
Benzinga Newsdesk - Sep 24, 2024, 8:13AM

Thursday, September 19, 2024

Arcutis Announces Publication Of Phase 3 Resu...
Benzinga Newsdesk - Sep 19, 2024, 8:07AM

Thursday, September 05, 2024

Arcutis Biotherapeutics Completes Enrollment ...
Benzinga Newsdesk - Sep 5, 2024, 8:06AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved